Amrutanjan Health Care Limited (NSE:AMRUTANJAN)
India · Delayed Price · Currency is INR 569.00
+7.95 (1.42%)
Jun 10, 2026, 3:29 PM IST
Amrutanjan Health Care Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 16,265 | 14,308 | 18,643 | 17,886 | 16,806 | 23,203 | |
Market Cap Growth | -17.75% | -23.25% | 4.23% | 6.42% | -27.57% | 39.69% |
Enterprise Value | 14,496 | 12,253 | 16,371 | 15,843 | 14,821 | 21,224 |
Last Close Price | 561.05 | 493.65 | 647.93 | 612.55 | 564.51 | 773.71 |
PE Ratio | 28.08 | 24.70 | 36.67 | 39.77 | 42.19 | 34.53 |
PS Ratio | 3.24 | 2.85 | 4.13 | 4.25 | 4.43 | 5.72 |
PB Ratio | 4.39 | 3.87 | 5.71 | 6.20 | 5.78 | 8.75 |
P/TBV Ratio | 4.41 | 3.88 | 5.74 | 6.25 | 5.83 | 8.83 |
P/FCF Ratio | - | - | 121.48 | 84.39 | 149.33 | 80.76 |
P/OCF Ratio | 45.22 | 39.78 | 36.63 | 64.08 | 83.28 | 44.45 |
EV/Sales Ratio | 2.88 | 2.44 | 3.62 | 3.76 | 3.90 | 5.23 |
EV/EBITDA Ratio | 21.29 | 18.00 | 28.00 | 30.45 | 32.32 | 25.56 |
EV/EBIT Ratio | 23.47 | 19.84 | 30.74 | 33.53 | 35.41 | 26.58 |
EV/FCF Ratio | -76.15 | - | 106.68 | 74.76 | 131.70 | 73.87 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.03 | 0.03 | 0.04 | 0.03 | 0.02 | 0.01 |
Debt / FCF Ratio | - | - | 0.14 | 0.08 | 0.08 | 0.03 |
Net Debt / Equity Ratio | -0.48 | -0.48 | -0.59 | -0.71 | -0.62 | -0.75 |
Net Debt / EBITDA Ratio | -2.60 | -2.60 | -3.30 | -3.95 | -3.96 | -2.41 |
Net Debt / FCF Ratio | 9.30 | 9.30 | -12.59 | -9.69 | -16.13 | -6.97 |
Asset Turnover | 1.08 | 1.08 | 1.15 | 1.16 | 1.07 | 1.30 |
Inventory Turnover | 7.56 | 7.56 | 8.15 | 7.52 | 6.84 | 8.46 |
Quick Ratio | 1.90 | 1.90 | 2.97 | 3.65 | 3.52 | 3.09 |
Current Ratio | 2.31 | 2.31 | 3.44 | 4.23 | 4.13 | 3.55 |
Return on Equity (ROE) | 16.62% | 16.62% | 16.53% | 15.53% | 14.33% | 27.96% |
Return on Assets (ROA) | 8.30% | 8.30% | 8.45% | 8.10% | 7.35% | 15.99% |
Return on Invested Capital (ROIC) | 27.85% | 28.12% | 36.18% | 35.68% | 35.70% | 111.22% |
Return on Capital Employed (ROCE) | 16.10% | 16.10% | 15.80% | 15.90% | 14.00% | 29.30% |
Earnings Yield | 3.56% | 4.05% | 2.73% | 2.51% | 2.37% | 2.90% |
FCF Yield | -1.17% | -1.33% | 0.82% | 1.19% | 0.67% | 1.24% |
Dividend Yield | 0.82% | 0.79% | 0.71% | 0.75% | 0.81% | 0.60% |
Payout Ratio | 22.79% | 22.79% | 26.10% | 29.77% | 36.17% | 18.57% |
Buyback Yield / Dilution | -0.02% | -0.02% | 0.38% | 0.71% | 0.03% | -0.00% |
Total Shareholder Return | 0.80% | 0.77% | 1.09% | 1.46% | 0.85% | 0.59% |